Second primary malignancies (SPMs) in patients with non-pulmonary well-differentiated neuroendocrine tumours (wdNETs)

Biochemistry, Genetics and Molecular Biology

• Colon 100%
• Mammalian Target of Rapamycin 100%
• Prevalence 100%
• Phosphoinositide 3-Kinase 100%
• Protein Kinase B 100%

Medicine and Dentistry

• Second Cancer 100%
• Neuroendocrine Tumor 100%
• Tumor Diagnosis 21%
• Breast Cancer 10%
• Prevalence 5%
• Colon 5%
• Disease Predisposition 5%
• Vermiform Appendix 5%
• Mammalian Target of Rapamycin 5%
• Colorectal Cancer 5%
• Pancreas Islet Cell Tumor 5%
• Phosphoinositide 3-Kinase 5%
• Neuroendocrine Differentiation 5%
• Colonoscopy 5%
• Protein Kinase B 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Neuroendocrine Tumor 100%
• Second Cancer 100%
• Colorectal Cancer 10%
• Breast Cancer 10%
• Prevalence 5%
• Disease Predisposition 5%
• Phosphatidylinositol 3 Kinase 5%
• Pancreas Islet Cell Tumor 5%
• Protein Kinase B 5%